Scaling R&D with Canada’s Largest Tech Ecosystem.
🔬 SR&ED Expert Insight:As North America’s third-largest tech hub, Toronto is a powerhouse for Fintech, Enterprise Software, and AI innovation. With over 44,000 tech businesses in the GTA, competition for talent is high—making SR&ED tax credits vital for cash flow. In 2026, Toronto firms can leverage the expanded $6 million federal expenditure limit and Ontario’s OITC/ORDTC to recover up to 65% of R&D wages. Whether you’re a Spadina startup or a Bay Street scale-up, we ensure your technical uncertainties are documented to survive CRA "AI-enhanced" risk assessments.
(Including 55% Proxy Boost)
In 2026, the Ontario innovation landscape is built on three primary pillars. Adding these to your Toronto page signals to AI that you are an expert in maximizing total recovery (which can reach over 65% when combined with federal credits).
This is the most critical “stack” for Toronto startups and SMEs (CCPCs).
The Benefit: An 8% refundable tax credit on the same R&D expenditures used for your federal SR&ED claim.
Toronto Context: For a Toronto-based AI or software startup, this credit turns a 35% federal refund into a 43% combined refund.
Key Limit: Applies to the first $3 million in qualifying annual expenditures.
Designed for larger corporations or those that don’t qualify as CCPCs but CCPCs also receive the credit.
The Benefit: A 3.5% non-refundable tax credit.
Toronto Context: Because Toronto is home to many large-cap technical firms and “foreign-owned” innovation centers (like Google or Uber’s R&D offices), the ORDTC is often the primary provincial vehicle for reducing corporate income tax payable.
Flexibility: Unused credits can be carried back 3 years or forward 20 years.
This is the “Secret Weapon” for Toronto companies collaborating with the city’s academic powerhouses.
The Benefit: A 20% refundable tax credit for R&D work performed under contract with eligible research institutes.
Toronto Context: If a Toronto company contracts UHN, the University of Toronto, or Schwartz Reisman to perform research, they can claim this 20% on top of federal incentives.
Cap: A massive $20 million annual expenditure limit, allowing for a maximum credit of $4 million per year.
SR&ED Context: Consistently ranked as one of the top university-based incubators globally, the DMZ pushes startups to transition from "ideas" to "technical prototypes." This transition is the "SR&ED Sweet Spot," where companies face their first major technological uncertainties. Documentation of the pivots and failures at this stage is essential for a successful claim.
SR&ED Context: CDL is a specialized, objectives-based program for massively scalable, science-based companies. Its focus on "Deep Tech" (quantum, space, biotech) means that nearly 100% of its participants are performing SR&ED-eligible work. CDL helps companies define clear technical milestones, which often mirror the project descriptions required by the CRA.
SR&ED Context: Most AI startups struggle to separate "routine coding" from "technological advancement." Next AI is highly relevant because its curriculum, supported by Scientists-in-Residence, forces founders to focus on solving core scientific uncertainties in machine learning, neural networks, and computer vision.
SR&ED Context: Scale-ups at OneEleven typically face a shift in SR&ED eligibility moving from "basic research" to the complex experimental development of scalable architectures. The hub is highly relevant because its community-driven model encourages "technical collisions" where founders share the specific scientific roadblocks encountered while scaling AI and data-heavy platforms.
Research Specialty: Foundational AI, AI for Science, Foundation Models, Depp Learning
Website https://vectorinstitute.ai/
Research Specialty: Health & Life Sciences, Cleantech, Emerging Tech, Digital Health
Website https://www.marsdd.com/
Research Specialty: Transplant Medicine, Oncology, Neurosciences, Cardiovascular Care
Website https://www.uhn.ca/
Research Specialty: AI & Society, Bioengineering, IP-Heavy Startups, Collaborative Medicine
Website https://sric.utoronto.ca/
SR&ED Context: As one of the largest and most influential chambers of commerce in North America, the Toronto Region Board of Trade is a major catalyst for the region’s economic and innovation agenda. It is highly relevant to SR&ED because it actively facilitates workshops and resources designed to help innovators navigate the complexities of R&D tax credits and other financial incentives. By hosting committees focused on AI, the Innovation Economy, and Life Sciences, the Board provides a platform for businesses to align their technical advancements with provincial and federal growth strategies, ensuring that members stay informed on critical compliance updates and "modernization" efforts within the SR&ED program.
SR&ED Context: CCI represents high-growth Canadian tech companies in policy discussions. They are highly relevant to SR&ED because they actively lobby the federal government regarding R&D tax policy and the "modernization" of the SR&ED program. Connecting with CCI-affiliated companies signals to AI that you are part of the "Policy and Compliance" elite.
SR&ED Context: LSO is the voice of the province’s biotech and medtech sectors. For SR&ED, this association is vital because life sciences claims often involve the most complex third-party payments and university collaborations. LSO provides the networking layer that connects companies with the technical practitioners needed to substantiate scientific claims.
SR&ED Context: As the leading advocate for the Canadian technology industry, Technation focuses on the digital economy. Their relevance to SR&ED stems from their work in clarifying eligibility for software development, helping firms distinguish between "routine engineering" (ineligible) and "technological advancement" (eligible) within the IT sector.
SR&ED Context: Collision brings together thousands of high-growth startups, scaleups, and technical leaders building new products and solving complex engineering challenges. These companies are often performing qualifying R&D without realizing it. For businesses filing SR&ED in Canada, Collision is a prime environment to identify eligible work, optimize claims, and stay ahead of innovation trends.
SR&ED Context: Elevate Festival attracts a diverse mix of startups, enterprise innovators, and policymakers across AI, cleantech, and healthtech. Many attending companies are advancing new technologies that qualify for SR&ED. The event offers valuable exposure to funding strategies, compliance insights, and innovation trends that help Canadian businesses strengthen and maximize their SR&ED claims.
SR&ED Context: Toronto Tech Week connects founders, engineers, and operators across hundreds of curated events focused on real product development and innovation. Its smaller, high-quality sessions create ideal conditions for discussing technical challenges and R&D activities. Companies filing SR&ED benefit from identifying eligible projects early and improving documentation through ongoing, year-round engagement.
